Exogenous Lipoid Pneumonia | NEJM
A 38-year-old woman with a history of disordered eating was found to have ground-glass opacities on a chest CT. Cytologic examination of bronchoalveolar-lavage fluid showed lipid-laden macrophages …
Related Articles
Are you sure you’re accurately measuring BP? Here’s how to know.
Accurate BP measurement is key to hypertension control, but care teams can overlook the task with dangerous consequences for patients. Learn more.
Trust in scientists and their role in society across 68 countries
Nature Human Behaviour – What is the state of trust in scientists around the world? To answer this question, the authors surveyed 71,922 respondents in…
Is your asthma inhaler bad for the environment?
A team of physician-scientists calculated how much greenhouse gas is being emitted by inhalers prescribed for asthma and chronic obstructive pulmonary disease.
Spotted hyena found in Egypt for the first time in 5,000 years
A spotted hyena (Crocuta crocuta) has been found in South Eastern Egypt: the first recorded instance of the creature in this region for thousands of…
Cross-sectional evaluation of medical reversals among National Institute of Health guideline practices implemented during the COVID-19 pandemic: how often did experts err in a time of crisis?
Objective The COVID-19 pandemic required the rapid and often widespread implementation of medical practices without robust data. Many of these practices have since been tested…
What Is a Generic Drug?
Are generic medications as good as brand-name drugs? A pharmacist has your answer.
Telix gets EU greenlight for Illuccix
Telix Pharmaceuticals announced a favorable decision from the European Union (EU) regarding marketing authorization for Illuccix in prostate cancer PET imaging.
7 Tips to Foster Effective Communication at the Workplace
Effective communication drives to better work performance while miscommunication costs money. Optimize your communication processes today.
Health Rounds: Drug cocktail helps keep liver cancer at bay
Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time patients lived without their disease getting…
Azvudine beats paxlovid in reducing COVID-19 deaths
In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with added antitumor effects observed.
